Doctor profile · Federal record
Dr. JOSEP GENEBRIERA DE LAMO, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · Student in an Organized Health Care Education/Training Program · JACKSONVILLE, FL
- NPI 1548418346
- Accepts Medicare
- MIPS 77.3 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1551 RIVERSIDE AVE
JACKSONVILLE, FL 322044124
(904) 354-4488
Credentials & registration
- NPI registered
- September 2008 — 18 yrs on file
- Profile last updated
- August 18, 2011
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Minnesota #51915
- Medicaid (2)
- IA #ENROLLED · MN #ENROLLED
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1548418346. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
12,944
Distinct HCPCS
10
Medicare allowed
$805,011
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 4,847 | 741 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 2,209 | 1,483 | $90 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,257 | 895 | $47 | |
11102 |
Biopsy of related skin growth, first growth | 1,063 | 888 | $86 | |
17110 |
Destruction of skin growth, 1-14 growths | 802 | 643 | $108 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 730 | 607 | $126 | |
11103 |
Biopsy of related skin growth, each additional growth | 381 | 262 | $50 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 259 | 60 | $1 | |
12032 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 191 | 168 | $298 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 160 | 160 | $111 |
In context: peer comparison
Among 19 peers in this city , average services per provider: 228. This provider delivers 57× the peer median.Open Payments
Industry payments received
All-time total
$15,210
Transactions
235
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Galderma Laboratories, L.P. | 23 | $10,364.05 | |
| Dermavant Sciences, Inc. | 25 | $911.95 | |
| ABBVIE INC. | 39 | $672.74 | |
| Arcutis Biotherapeutics, Inc. | 19 | $523.50 | |
| Janssen Biotech, Inc. | 25 | $496.04 | |
| Novartis Pharmaceuticals Corporation | 29 | $396.70 | |
| GENZYME CORPORATION | 10 | $366.26 | |
| Regeneron Healthcare Solutions, Inc. | 12 | $276.12 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $249.86 | |
| E.R. Squibb & Sons, L.L.C. | 12 | $228.73 | |
| Lilly USA, LLC | 11 | $147.67 | |
| UCB, Inc. | 8 | $147.55 | |
| Amgen Inc. | 4 | $107.63 | |
| PFIZER INC. | 5 | $95.06 | |
| Incyte Corporation | 5 | $92.65 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,784
Patients
1,633
Total drug cost
$205,855
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 539 | 335 | $7,666 |
| Ketoconazole | Generic | 448 | 221 | $8,897 |
| Clobetasol Propionate | Generic | 439 | 268 | $26,256 |
| Hydrocortisone | Generic | 381 | 235 | $2,436 |
| Doxycycline Hyclate | Generic | 259 | 162 | $6,306 |
| Prednisone | Generic | 207 | 134 | $622 |
| Nystatin | Generic | 161 | 102 | $2,272 |
| Ciclopirox | Generic | 97 | 34 | $2,455 |
| Hydroxyzine Hcl | Generic | 55 | 28 | $462 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 45 | 28 | $688 |